Clinical Trials Logo

Recurrent or Metastatic Disease clinical trials

View clinical trials related to Recurrent or Metastatic Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT01289522 Active, not recruiting - Clinical trials for Squamous Cell Head and Neck Carcinoma

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Start date: September 2009
Phase: Phase 2
Study type: Interventional

PURPOSE: Cetuximab with platinum and 5FU is now the standard combination as first-line treatment in patients with metastatic or recurrent Head and Neck squamous cell carcinomas. Cetuximab and taxane combinations have demonstrated promising activity in Head and Neck cancer. This phase II trial is studying new cetuximab, docetaxel and cisplatin combination named TPEx as first-line treatment in this setting.